Clinical Trials Directory

Trials / Completed

CompletedNCT02328404

The Effect of Vitamin D Supplementation Among Overweight Jordanian Women With Polycystic Ovary Syndrome (PCOS)

The Effect of Vitamin D Supplementation on Chromium Serum Levels and Insulin Resistance Among Overweight Jordanian Women With Polycystic Ovary Syndrome in Irbid

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Hayat Pharmaceutical Co. PLC · Industry
Sex
Female
Age
18 Years – 49 Years
Healthy volunteers
Accepted

Summary

This is a prospective double-blind, randomized, parallel-group, placebo-controlled trial designed to examine the effect of supplementation with 50,000 IU vitamin D3 for 3 months on Polycystic Ovary Syndrome (PCOS) prognosis, serum 25-Hydroxy Vitamin D (25(OH)D) level, serum chromium level, insulin resistance, and Body Mass Index (BMI), in 60 overweight Jordanian female patients diagnosed with PCOS and with hypovitaminosis D.

Detailed description

This study is designed to assess the safety and efficacy of 50,000 IU vitamin D supplementation once weekly for 3 months on improvement in PCOS prognosis and improvement in serum 25(OH)D levels in 60 overweight Jordanian females (defined as having a BMI 25-30kg/m2), diagnosed with PCOS (based on Rotterdam criteria), and with hypovitaminosis D (defined as a serum 25(OH)D level \< 20 ng/mL), compared with placebo. Evaluation of the safety and efficacy of the dosing regimen will be conducted over 6 study visits during which clinical and biochemical signs of PCOS as well as serum 25(OH)D level, serum chromium level, insulin resistance, and BMI will be evaluated. The measurements will be collected as follows : day (-7) during screening , Day (0) base line measurements , Day (30) , Day(60), Day (90), day (104).

Conditions

Interventions

TypeNameDescription
DRUG50,000 IU vitamin D3Film-coated tablet Biodal 50,000 IU containing cholecalciferol 50,000 IU
DRUGPlaceboPlacebo film-coated tablet of Biodal 50,000 IU

Timeline

Start date
2014-02-01
Primary completion
2014-09-01
Completion
2014-12-01
First posted
2014-12-31
Last updated
2016-08-04
Results posted
2015-04-17

Locations

1 site across 1 country: Jordan

Source: ClinicalTrials.gov record NCT02328404. Inclusion in this directory is not an endorsement.